[
  {
    "ts": null,
    "headline": "From Apple to GM, Tariffs to Cost Companies Tens of Billions",
    "summary": "(Bloomberg) -- From Apple Inc. to General Motors Co., corporate America is bracing for tens of billions of dollars in damages from Trump’s trade war — and that’s before most affected goods have landed.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesLA Mayor Credits T",
    "url": "https://finnhub.io/api/news?id=3022292d41dad23f3268df89f56ef41fcb1b74d88d4dd7e87551f92749aeba0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746741522,
      "headline": "From Apple to GM, Tariffs to Cost Companies Tens of Billions",
      "id": 134335656,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- From Apple Inc. to General Motors Co., corporate America is bracing for tens of billions of dollars in damages from Trump’s trade war — and that’s before most affected goods have landed.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesLA Mayor Credits T",
      "url": "https://finnhub.io/api/news?id=3022292d41dad23f3268df89f56ef41fcb1b74d88d4dd7e87551f92749aeba0e"
    }
  },
  {
    "ts": null,
    "headline": "A Look at Pharma ETFs After Strong Q1 Earnings",
    "summary": "Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.",
    "url": "https://finnhub.io/api/news?id=268af555da3b9bc4ff0a37ee029804289b139cc81c8494abb1cab238bec319ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746719400,
      "headline": "A Look at Pharma ETFs After Strong Q1 Earnings",
      "id": 134335780,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.",
      "url": "https://finnhub.io/api/news?id=268af555da3b9bc4ff0a37ee029804289b139cc81c8494abb1cab238bec319ce"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Equity Income Fund Q1 2025 Commentary",
    "summary": "Hartford Equity Income Fund (I Share) outperformed the Russell 1000 Value Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=dfc18cc6bba6eb4df2059eae68ccfdf672f2feb49bdf0816ed5c20a4d712173b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746716700,
      "headline": "Hartford Equity Income Fund Q1 2025 Commentary",
      "id": 134329054,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187991365/image_2187991365.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Hartford Equity Income Fund (I Share) outperformed the Russell 1000 Value Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=dfc18cc6bba6eb4df2059eae68ccfdf672f2feb49bdf0816ed5c20a4d712173b"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746715560,
      "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
      "id": 134328189,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1406458240/image_1406458240.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Dividend Income Fund Q1 2025 Commentary",
    "summary": "The fund outperformed the Russell 1000 Value Index due to strong stock selection in several sectors, despite underperformance in information technology, materials and financials.",
    "url": "https://finnhub.io/api/news?id=0cdb7deddc9ccbb54d971cd971231977205e5a43f99a9e9d6e1f3f3d0a09afc7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746707520,
      "headline": "Invesco Dividend Income Fund Q1 2025 Commentary",
      "id": 134327085,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The fund outperformed the Russell 1000 Value Index due to strong stock selection in several sectors, despite underperformance in information technology, materials and financials.",
      "url": "https://finnhub.io/api/news?id=0cdb7deddc9ccbb54d971cd971231977205e5a43f99a9e9d6e1f3f3d0a09afc7"
    }
  },
  {
    "ts": null,
    "headline": "Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook",
    "summary": "Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates.",
    "url": "https://finnhub.io/api/news?id=808641dda5cc001196f1d97833690fa86f682b59d98b17623be4971a29bd4aca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746706920,
      "headline": "Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook",
      "id": 134325242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates.",
      "url": "https://finnhub.io/api/news?id=808641dda5cc001196f1d97833690fa86f682b59d98b17623be4971a29bd4aca"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson expands efforts to champion the nursing workforce globally",
    "summary": "NEW BRUNSWICK, N.J., May 08, 2025--Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the global shortfall of nu",
    "url": "https://finnhub.io/api/news?id=596c1f4645fe44a534a5110c88758fd1a840622de14d2658e14816fd5485bab0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746706320,
      "headline": "Johnson & Johnson expands efforts to champion the nursing workforce globally",
      "id": 134325243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J., May 08, 2025--Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the global shortfall of nu",
      "url": "https://finnhub.io/api/news?id=596c1f4645fe44a534a5110c88758fd1a840622de14d2658e14816fd5485bab0"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Diversified Dividend Fund Q1 2025 Commentary",
    "summary": "In an environment characterized by high uncertainty, we believe investors will place greater emphasis on companies with stable dividends.",
    "url": "https://finnhub.io/api/news?id=f8b0e2a820238b332cff6ac7c28b956a71194708aa4edc710fa887190471b21e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746700500,
      "headline": "Invesco Diversified Dividend Fund Q1 2025 Commentary",
      "id": 134324383,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2193247029/image_2193247029.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "In an environment characterized by high uncertainty, we believe investors will place greater emphasis on companies with stable dividends.",
      "url": "https://finnhub.io/api/news?id=f8b0e2a820238b332cff6ac7c28b956a71194708aa4edc710fa887190471b21e"
    }
  },
  {
    "ts": null,
    "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
    "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
    "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746696282,
      "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
      "id": 134323621,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1169172518/image_1169172518.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
      "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Equity Income Fund Q1 2025 Commentary",
    "summary": "Franklin Equity Income Fund's Q1 2025 report provides insights into market trends, fund performance, key sector contributions, and outlook. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=e06a7cd876551c4d5cd71d318c552b5fa90c440828cdea6db791e2b6e8c6f049",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746691800,
      "headline": "Franklin Equity Income Fund Q1 2025 Commentary",
      "id": 134322737,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1456260650/image_1456260650.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Franklin Equity Income Fund's Q1 2025 report provides insights into market trends, fund performance, key sector contributions, and outlook. Click here to read more. ",
      "url": "https://finnhub.io/api/news?id=e06a7cd876551c4d5cd71d318c552b5fa90c440828cdea6db791e2b6e8c6f049"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Small Cap Growth Fund Q1 2025 Commentary",
    "summary": "The Franklin Small Cap Growth Fund underperformed its Russell 2000 Growth Index benchmark in the first quarter of 2025. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=704795925a307a54f1844c341d520703602751a477819bfc9f14c7c189120866",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746690300,
      "headline": "Franklin Small Cap Growth Fund Q1 2025 Commentary",
      "id": 134322498,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210972256/image_2210972256.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Franklin Small Cap Growth Fund underperformed its Russell 2000 Growth Index benchmark in the first quarter of 2025. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=704795925a307a54f1844c341d520703602751a477819bfc9f14c7c189120866"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Global Allocation Fund Q1 2025 Commentary",
    "summary": "Over the first quarter of 2025, Franklin Global Allocation Fund proved more resilient than its benchmark. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=4c739cfb99f3a8927149972d539d6ccbb89681670bf899266ee14ed69306f26c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746685500,
      "headline": "Franklin Global Allocation Fund Q1 2025 Commentary",
      "id": 134321355,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1484736771/image_1484736771.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Over the first quarter of 2025, Franklin Global Allocation Fund proved more resilient than its benchmark. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=4c739cfb99f3a8927149972d539d6ccbb89681670bf899266ee14ed69306f26c"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equity And Income Fund Q1 2025 Commentary",
    "summary": "We added new holdings in the industrials, health care and energy sectors, purchases that were funded by sales across several different sectors, including one IT holding.",
    "url": "https://finnhub.io/api/news?id=632ce773a75127e3e9677f6dd7be97da784b55149e1a7590e1d2010257ba1016",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746683580,
      "headline": "Invesco Equity And Income Fund Q1 2025 Commentary",
      "id": 134321073,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164504974/image_2164504974.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "We added new holdings in the industrials, health care and energy sectors, purchases that were funded by sales across several different sectors, including one IT holding.",
      "url": "https://finnhub.io/api/news?id=632ce773a75127e3e9677f6dd7be97da784b55149e1a7590e1d2010257ba1016"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Hikes Offer Optimism Amid Tariff Turmoil",
    "summary": "Stocks have rebounded sharply off their early-April lows, but macro risks persist.",
    "url": "https://finnhub.io/api/news?id=f98d171acf0f2677696768a10207f7a9239f331320224fd1228097109b49bf19",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746665100,
      "headline": "Dividend Hikes Offer Optimism Amid Tariff Turmoil",
      "id": 134314621,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1617841301/image_1617841301.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Stocks have rebounded sharply off their early-April lows, but macro risks persist.",
      "url": "https://finnhub.io/api/news?id=f98d171acf0f2677696768a10207f7a9239f331320224fd1228097109b49bf19"
    }
  }
]